Location History:
- Kikuchi, JP (2010 - 2012)
- Kumamoto, JP (2020)
Company Filing History:
2 out of 114 
1 out of 24 Years Active: 2010-2020
Title: Reiko Matsuyama: Innovator in Biopharmaceuticals
Introduction
Reiko Matsuyama is a notable inventor based in Kikuchi, Japan. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of methods for protein monomerization and recombinant cell production. With a total of 3 patents, Matsuyama's work has the potential to impact therapeutic applications significantly.
Latest Patents
Matsuyama's latest patents include a method for monomerizing matrix metalloproteinase 7 (MMP-7) aggregates. This innovative method involves treating MMP-7 aggregates with a buffer solution containing a monovalent cation chloride at low concentrations or using a buffer solution without such cations. Additionally, he has developed a process for producing recombinant fibrinogen highly producing cells. This process incorporates genes encoding the three proteins that constitute fibrinogen into animal cells, optimizing the production of these essential proteins.
Career Highlights
Throughout his career, Matsuyama has worked with esteemed organizations such as the Chemo-Sero-Therapeutic Research Institute and Km Biologics Co., Ltd. His research has focused on enhancing the efficiency of protein production, which is crucial for developing effective biopharmaceuticals.
Collaborations
Matsuyama has collaborated with notable colleagues, including Hiroaki Maeda and Hitomi Shirahama. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of biopharmaceutical research.
Conclusion
Reiko Matsuyama's contributions to biopharmaceuticals through his innovative patents and collaborative efforts highlight his role as a key figure in advancing medical science. His work continues to pave the way for new therapeutic solutions.